Dr Reddys Laboratories (RDY) Change in Cash (2009 - 2018)

Dr Reddys Laboratories (RDY) has reported Change in Cash for 8 consecutive years, with $1.8 billion the latest figure, recorded in Q1 2018.

• Quarterly Change in Cash changed N/A year-over-year to $1.8 billion in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $4.7 billion (changed N/A YoY) and the FY2026 annual result came in at -$5.0 million, down 105.88% from the prior year.
• Change in Cash grew to $1.8 billion in Q1 2018 per RDY's latest filing, from -$461.0 million in the prior quarter.
• Over the last five years, Change in Cash for RDY reached as high as $3.8 billion in Q4 2016 and fell as low as -$3.8 billion in Q3 2016.
• A 3-year average of $171.4 million and a median of -$459.0 million in 2017 frame the typical range for Change in Cash.
• The largest YoY upside for Change in Cash was 87.96% in 2017 against a maximum downside of 112.22% in 2017.
• Year by year, Change in Cash stood at $3.8 billion in 2016, then plunged by 112.22% to -$461.0 million in 2017, then soared by 493.71% to $1.8 billion in 2018.
• According to Business Quant data, Change in Cash over the past three periods registered $1.8 billion, -$461.0 million, and -$459.0 million for Q1 2018, Q4 2017, and Q3 2017 respectively.